carbinoxamine maleate (Biocomp Pharma, Inc.)
Welcome to the PulseAid listing for the carbinoxamine maleate drug offered from Biocomp Pharma, Inc.. This Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Biocomp Pharma, Inc. |
NON-PROPRIETARY NAME: | carbinoxamine maleate |
SUBSTANCE NAME: | CARBINOXAMINE MALEATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-05-27 |
END MARKETING DATE: | 0000-00-00 |
carbinoxamine maleate HUMAN PRESCRIPTION DRUG Details:
Item Description | carbinoxamine maleate from Biocomp Pharma, Inc. |
LABELER NAME: | Biocomp Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4(mg/1) |
START MARKETING DATE: | 2011-05-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 44523-825_14266e97-674b-b6a9-37a2-a955f0a01c4f |
PRODUCT NDC: | 44523-825 |
APPLICATION NUMBER: | ANDA090756 |
Other CARBINOXAMINE MALEATE Pharmaceutical Manufacturers / Labelers: